Alpha Cognition Inc. $ACOG Shares Sold by Villere ST Denis J & Co. LLC

Villere ST Denis J & Co. LLC lowered its stake in shares of Alpha Cognition Inc. (NASDAQ:ACOGFree Report) by 11.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 63,838 shares of the company’s stock after selling 7,940 shares during the quarter. Villere ST Denis J & Co. LLC owned approximately 0.40% of Alpha Cognition worth $596,000 as of its most recent filing with the Securities and Exchange Commission.

Separately, Salem Investment Counselors Inc. acquired a new stake in shares of Alpha Cognition during the first quarter worth approximately $230,000.

Alpha Cognition Price Performance

Alpha Cognition stock opened at $7.02 on Friday. The company has a market cap of $146.72 million, a PE ratio of -4.39 and a beta of 2.63. The company has a fifty day moving average price of $8.36 and a two-hundred day moving average price of $8.05. Alpha Cognition Inc. has a 12 month low of $3.75 and a 12 month high of $11.54.

Alpha Cognition (NASDAQ:ACOGGet Free Report) last released its quarterly earnings data on Thursday, August 14th. The company reported ($0.65) EPS for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.19). The business had revenue of $1.66 million for the quarter, compared to analysts’ expectations of $2.32 million.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised shares of Alpha Cognition from a “sell” rating to a “hold” rating in a research report on Saturday, August 30th. One equities research analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $20.00.

Check Out Our Latest Stock Analysis on Alpha Cognition

Insiders Place Their Bets

In related news, Director Robert James Wills bought 15,000 shares of the business’s stock in a transaction on Monday, August 18th. The shares were bought at an average cost of $8.49 per share, for a total transaction of $127,350.00. Following the completion of the purchase, the director owned 15,000 shares of the company’s stock, valued at $127,350. This represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Phillip Joseph Mertz sold 27,778 shares of the firm’s stock in a transaction on Monday, August 18th. The shares were sold at an average price of $9.00, for a total value of $250,002.00. Following the completion of the sale, the director owned 22,462 shares in the company, valued at $202,158. The trade was a 55.29% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 14.00% of the company’s stock.

Alpha Cognition Company Profile

(Free Report)

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.

See Also

Institutional Ownership by Quarter for Alpha Cognition (NASDAQ:ACOG)

Receive News & Ratings for Alpha Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Cognition and related companies with MarketBeat.com's FREE daily email newsletter.